2015
DOI: 10.1039/c5cc07989f
|View full text |Cite
|
Sign up to set email alerts
|

Near-IR mediated intracellular uncaging of NO from cell targeted hollow gold nanoparticles

Abstract: NIR light triggers NO delivery with unprecedented spatio-temporal control inside prostate cancer cells from surface-modified hollow gold nanoshells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
20
0
1

Year Published

2016
2016
2019
2019

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 38 publications
(22 citation statements)
references
References 30 publications
(40 reference statements)
1
20
0
1
Order By: Relevance
“…Recently, Tortiglione and co‐workers developed a gold nanoparticle containing microcapsule and demonstrated that near‐infrared light can control the Wnt/β‐catenin signaling pathway in Hydra via photothermal uncaging of alkaline phosphatase . Efficient photothermal‐mediated uncaging requires continuous light irradiation and takes minutes or even hours . In addition to the slow uncaging, heat‐induced damage to proteins remains another major limitation.…”
Section: Introductionmentioning
confidence: 99%
“…Recently, Tortiglione and co‐workers developed a gold nanoparticle containing microcapsule and demonstrated that near‐infrared light can control the Wnt/β‐catenin signaling pathway in Hydra via photothermal uncaging of alkaline phosphatase . Efficient photothermal‐mediated uncaging requires continuous light irradiation and takes minutes or even hours . In addition to the slow uncaging, heat‐induced damage to proteins remains another major limitation.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, NO has been reported to reverse the MDR of cancer cells by reducing the expression level of P‐gp, which promptes the development of new NO delivery systems for MDR cancer chemotherapy . However, NO has a short half‐life and high sensitivity to biological substances, which greatly restricts the development of NO‐based therapeutic system in clinical applications . Furthermore, low NO concentration may promoting the growth of tumor .…”
Section: Methodsmentioning
confidence: 99%
“…The gaseous nature has made their targeted delivery and controlled administration more challenging 108a,111. In the past two decades, researchers have developed various donors for NO and CO that are able to release the gaseous molecules under certain stimuli, such as pH, heat, and light, and some of them are already commercially available.…”
Section: Combination With Novel Oncotherapymentioning
confidence: 99%